Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14ClN3O |
InChIKeyJMLJEYLWRAPHBL-UHFFFAOYSA-N |
CAS Registry2439271-82-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 26 Apr 2021 |